Drug Type Small molecule drug |
Synonyms ZL-65 |
Target |
Action modulators |
Mechanism NLRP3 modulators(NACHT, LRR and PYD domains-containing protein 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cryopyrin-Associated Periodic Syndromes | Preclinical | China | 22 Aug 2024 | |
Multiple Sclerosis | Preclinical | China | 22 Aug 2024 | |
Autoinflammatory disease | Preclinical | China | 22 Mar 2024 | |
Gout | Preclinical | China | 12 Oct 2022 | |
Nonalcoholic Steatohepatitis | Preclinical | China | 12 Oct 2022 |